Spironolactone Tablet
Product Images NDC 70518-4447

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70518-4447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Spironolactone 100mg 70518 4447 00)

Spironolactone 100 mg tablet packaging label showing a quantity of 100 tablets per box. The label includes storage instructions, repackaging information by RemedyRepack Inc., and identification details including NDC number and manufacturer location in India. The tablets are round and white.*

FDA Label Image

Mm2 (Spironolactone 100mg 70518 4447 01)

Spironolactone Tablet 100 mg oral tablet repackaged by RemedyRepack Inc. The label indicates a quantity of 1 tablet, round white in shape, manufactured by Aurobindo in India. Storage instructions specify temperatures between 20-25°C with excursions allowed to 15-30°C. The product is prescription only.*

FDA Label Image

Figure (Spironolactone Fig1)

A survival probability graph comparing Spironolactone and placebo groups over 48 months. The y-axis shows probability from 0.1 to 1.0, and the x-axis shows time in months from 0 to 48. The Spironolactone group (n=822) has higher survival probability over time than the placebo group (n=841). A log-rank p-value of less than 0.001 is indicated.*

FDA Label Image

Fig2 (Spironolactone Fig2)

A forest plot showing hazard ratios (HR) and 95% confidence intervals (CI) for various subgroups in a study comparing spironolactone versus placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin use, ACE inhibitor use, and beta blocker use. Each subgroup is indicated with a point estimate and CI line, with HR values plotted on a scale from 0.2 to 1.4, where values left of 1.0 favor spironolactone and values right favor placebo.*

FDA Label Image

Str1 (Spironolactone Str1)

Chemical structure of spironolactone, showing its steroidal framework with labeled functional groups including a ketone, lactone ring, and methylthio substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.